Randy D. Hicks, M.D., M.B.A.
Dr. Hicks, co-owner and CEO of RMI, is a distinguished expert on women’s imaging who has co-authored several medical journal articles on topics related to imaging for breast cancer. He also has special interest and expertise in parathyroid and thyroid imaging, interventional breast biopsy procedures, and product development.
He is a committed advocate for women’s healthcare, especially for breast cancer prevention, early detection, and treatment. Dr. Hicks works closely with medical colleagues to encourage multidisciplinary, best-practice approaches to care. This includes such efforts as establishing local “tumor boards” that bring together radiologists, surgeons, oncologists, and other physicians from leading health systems and practices in the region.
He serves as a thought leader and spokesperson for the role of information technology in enhancing the quality and efficiency of health care. He led RMI’s efforts as the first radiology practice to achieve Meaningful Use (electronic health records) implementation.
A graduate of Michigan State University’s College of Human Medicine, Dr. Hicks completed a residency in diagnostic radiology at Michigan State University Affiliated Hospitals, and was board certified by the American Board of Radiology in 1989. After joining RMI in 1989, Dr. Hicks also earned an MBA enabling him to direct our growing organization and better serve patients and the community.
The lifelong Michigan native completed his undergraduate degree at Kalamazoo College. Other education includes:
Medical School Education: 1984, Michigan State University, College of Human Medicine
Internship: 1984–1985, Michigan State University Affiliated Hospitals
Residency: 1985–1989, Michigan State University Affiliated Hospitals (Chief Resident 1987–1988)
Board Certified: 1989, American Board of Radiology
MBA: 1997, Program and Integrative Management, Michigan State University, The Eli Broad Graduate School of Management
His leadership role also includes service on various boards and advisory committees including:
- Michigan Radiological Society (Board of Directors), Co-chair of the Finance & Budget committee and Chair of the Automation & Technology committee
- Hologic, a manufacturer of diagnostic and medical imaging equipment focused on women’s health
- Merge Healthcare (advisory), a leading provider of enterprise imaging and interoperability solutions in radiology, cardiology, and orthopedics
- The State Bank (Board of Directors), a local financial institution based in Fenton
- Fentura, Inc. (Board of Directors), parent company of The State Bank
David A. Strahle, M.D.
Dr. Strahle’s early interest aviation, beginning in 1965, led to his becoming an avid pilot and flight instructor. By the age of 21, he had already taught hundreds of people to fly in the Flint community. Expanding on his extensive aviation background, Dr. Strahle graduated cum laude with a degree in aerospace technology in 1972, which included studies in aeronautics and advanced computer systems. During his senior year, his research paper won first place at the American Institute of Aeronautics and Astronautics (AIAA) Research Forum. It presented a new concept for identifying and tracking thunderstorms, which was installed nationwide in 2000. As discussed below, this research paper would have an impact later in his medical career.
His background eventually led to an upper-level position with IBM, through which he earned an equivalent of a master’s degree in 1974. He was assigned to IBM’s largest commercial account, the Chevrolet Motor Car Division of General Motors, where his responsibility included all 23 Chevrolet Manufacturing Plants.
Subsequently, the field of medicine caught his interest, and he left IBM to return to pre-med courses, in which he achieved a 4.0 grade point average. He entered medical school as the first student to be accepted in his class of 100 positions. During medical school, he continued to teach flying at the Lansing Community College Aviation Center.
Michigan State University’s Medical School is unique. The first two years are on the MSU campus in Lansing, and the last two years are off-site at one of five locations in Michigan. Dr. Strahle chose to complete the last two years of his medical training in Flint. This included rotations through all three of Flint’s hospitals, working with most of the community physicians. In his first year following medical school, he completed an internship at McLaren General Hospital in Flint, rotating between internal medicine, radiology and surgery.
Near the end of his internship year, Dr. Strahle was approached by Michigan State University with a proposal to organize, initiate and operate a diagnostic radiology residency program in the Flint area. In the spring of 1982, he was the first and only resident in the newly developed Flint Diagnostic Radiology Residency Program. He developed and controlled most of the program, including the rotation schedule and the call schedule between all three of Flint’s hospitals. This gave him direct one-on-one training with the instructors at the radiology department of Michigan State University.
Dr. Strahle passed his first written and oral boards (including the radiation section of the written boards) in the spring of 1985. As a new Board Certified diagnostic radiologist, he started his private diagnostic radiology practice at 2486 Nerredia Street in Flint, Michigan, in the fall of 1985. Blending his unique approach to the radiological problems facing the medical community (technological expansion of diagnostic radiology at a rapid pace) and his professional contacts within the community, the practice grew rapidly, acquiring first a radiology physician’s assistant and, second, Dr. Randy D. Hicks, who in 1989 had completed the radiology residency program that Dr. Strahle started four years earlier.
The practice continued rapid growth to its current seven offices offering all imaging modalities allowed by the State of Michigan, including the acquisition of five (5) CONs (Certificate of Need) from the State of Michigan for the installation, over time, of three CT scanners and two MRI scanners. Dr. Strahle continues as an assistant clinical professor for the radiology department at Michigan State University, College of Human Medicine, and is currently President and Chairman of Regional Medical Imaging, PC.
In 2004 Dr. Strahle was notified of innovative Breast MRI research taking place on the West Coast. It was similar to Dr. Strahle’s prior development of the above-mentioned advanced radar reports for the aviation community (these aviation reports are currently produced every hour by each of 140 radar sites across the country using the protocols established by Dr. Strahle).
Intrigued, Dr. Strahle developed an intense drive to develop 4-D (four-dimensional) breast MRI. For nearly a year, Dr. Strahle worked seven days a week on developing new protocols to markedly increase the ability to detect breast cancer at an early stage using MRI.
- “Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging.” Published on Springer, January 30, 2017. Publication based on Dr. Strahle’s seven year research study of “rapid” breast MRI protocol.
- “Nodal Positivity in Breast Cancer Correlated with the Number of Lesions Detected by Magnetic Resonance Imaging versus Mammogram.” Presented at the 53rd Annual Conference, Midwest Surgical Association.
- “The Prognostic Value of Additional Malignant Lesions Detected by Magnetic Resonance Imaging versus Mammography.” Presented at The American Society of Breast Surgeons, Chicago, IL.
- “Routine Screening of Women for Occult Breast Cancer Using a Simplified Breast MR Protocol in Place of Screening Mammograms.” Presented at the Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting, November 2012, Chicago, IL.
- $1 million grant successfully acquired for Screening Breast MRI Initiative project, June 2009 to June 2011.
- Independent Review Board approval of Screening Breast MRI Initiative—Prospective Trial Comparing Mammograms and MRI in Breast Cancer Screening.
- ICE3 Clinical Trial – cryoablation of breast malignant tumors under ultrasound guidance.
Product Development & Advisory Positions
- MERGE Healthcare – national showcase site for PACS and RIS
- Hologic, Inc. – MR guided breast imaging devices test site.
- Siemens – test site for 3D vascular imaging workstations.
- RBMA (Radiological Business Management Association) – three advisory seats.
- Michigan State Radiological Society – one seat on the Board of Trustees.